Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Stöger Herbert |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2022

Originalarbeit (Zeitschrift)

** Gampenrieder, SP; Pircher, M; Fesl, C; Rinnerthaler, G; Mlineritsch, B; Greil-Ressler, S; Steger, GG; Sagaster, V; Fitzal, F; Exner, R; Devyatko, Y; Balic, M; Stöger, H; Suppan, C; Bauernhofer, T; Singer, CF; Pfeiler, G; Seifert, M; Helfgott, R; Heck, D; Rumpold, H; Kwasny, W; Wieder, U; Gnant, M; Greil, R Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Breast Care (Basel). 2022; 17(2):137-145 Doi: 10.1159/000516157 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

** Singer, CF; Holst, F; Steurer, S; Burandt, EC; Lax, SF; Jakesz, R; Rudas, M; Stoger, H; Greil, R; Sauter, G; Filipits, M; Simon, R; Gnant, M; Abcsg, ABCSG Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer
CLIN CANCER RES. 2022; 28(18): 4112-4120. Doi: 10.1158/1078-0432.CCR-21-4328 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Balic, M; Posch, F; Dandachi, N; Hauser-Kronberger, C; Reitsamer, R; Sotlar, K; Radl, B; Suppan, C; Stöger, H; Greil, R Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT).
Breast Care (Basel). 2022; 17(1): 1-9. Doi: 10.1159/000512467 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

2021

Originalarbeit (Zeitschrift)

** Bartsch, R; Singer, CF; Pfeiler, G; Hubalek, M; Stoeger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Muy-Kheng, TM; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.
Br J Cancer. 2021; 124(11): 1795-1802. Doi: 10.1038/s41416-021-01284-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Gampenrieder, SP; Pircher, M; Fesl, C; Rinnerthaler, G; Mlineritsch, B; Greil-Ressler, S; Steger, GG; Sagaster, V; Fitzal, F; Exner, R; Devyatko, Y; Balic, M; Stoger, H; Suppan, C; Bauernhofer, T; Singer, CF; Pfeiler, G; Seifert, M; Helfgott, R; Heck, D; Rumpold, H; Kwasny, W; Wieder, U; Gnant, M; Greil, R Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
BREAST CARE. 2021; Doi: 10.1159/000516157
Web of Science FullText FullText_MUG

 

** Gnant, M; Fitzal, F; Rinnerthaler, G; Steger, GG; Greil-Ressler, S; Balic, M; Heck, D; Jakesz, R; Thaler, J; Egle, D; Manfreda, D; Bjelic-Radisic, V; Wieder, U; Singer, CF; Melbinger-Zeinitzer, E; Haslbauer, F; Sevelda, P; Trapl, H; Wette, V; Wimmer, K; Gampenrieder, SP; Bartsch, R; Kacerovsky-Strobl, S; Suppan, C; Brunner, C; Deutschmann, C; Soelkner, L; Fesl, C; Greil, R, , Austrian, Breast, and, Colorectal, Cancer, Study, Group;Austrian, Breast, and, Colorectal, Cancer, Study, Group Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
N Engl J Med. 2021; 385(5):395-405 Doi: 10.1056/NEJMoa2104162
Web of Science PubMed FullText FullText_MUG

 

** Mollnar, S; Pondorfer, P; Kasparek, AK; Reinisch, S; Moik, F; Stotz, M; Halm, M; Szkandera, J; Terbuch, A; Eisner, F; Gerger, A; Kapp, KS; Partl, R; Vasicek, S; Weiland, T; Pichler, M; Stöger, H; Thurnher, D; Posch, F Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy.
Clin Transl Oncol. 2021; 23(3):543-553 Doi: 10.1007/s12094-020-02447-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Hasenleithner, SO; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stöger, H; Berghold, A; Hoefler, G; Speicher, MR; Heitzer, E; Gerger, A Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
Ther Adv Med Oncol. 2021; 13:1758835920987658 Doi: 10.1177/1758835920987658 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, DA; Rossmann, CH; Stotz, M; Schaberl-Moser, R; Pichler, M; Stöger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
Eur J Cancer. 2021; 151: 3-13. Doi: 10.1016/j.ejca.2021.03.040 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stoeger, H; Leithner, A; Heitzer, E; Liegl-Atzwanger, B; Szkandera, J Molecular profiling of soft-tissue sarcomas with FoundationOne® Heme identifies potential targets for sarcoma therapy: a single-centre experience.
Ther Adv Med Oncol. 2021; 13:17588359211029125 Doi: 10.1177/17588359211029125 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Scheipner, L; Smolle, MA; Barth, D; Posch, F; Stotz, M; Pichler, M; StÖger, H; Gerger, A; Riedl, JM The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma.
Anticancer Res. 2021; 41(1):429-436 Doi: 10.21873/anticanres.14792
Web of Science PubMed FullText FullText_MUG

 

** Suppan, C; Steiner, D; Klocker, EV; Posch, F; Henzinger, E; Muller, HD; Stoger, H; Dandachi, N; Balic, M Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer Patients
BREAST CARE. 2021; Doi: 10.1159/000513766 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Vigier, M; Thorson, KR; Andritsch, E; Stoeger, H; Suerth, L; Farkas, C; Schwerdtfeger, AR Physiological linkage during interactions between doctors and cancer patients.
Soc Sci Med. 2021; 284:114220 Doi: 10.1016/j.socscimed.2021.114220 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Balic, M; Posch, F; Dandachi, N; Hauser-Kronberger, C; Reitsamer, R; Sotlar, K; Radl, B; Suppan, C; Stoger, H; Greil, R Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT)
BREAST CARE. 2021; Doi: 10.1159/000512467
Web of Science FullText FullText_MUG

 

2020

Originalarbeit (Zeitschrift)

** Barth, DA; Brenner, C; Riedl, JM; Prinz, F; Klocker, EV; Schlick, K; Kornprat, P; Lackner, K; Stöger, H; Stotz, M; Gerger, A; Pichler, M External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients.
Cancer Med. 2020; 9(15):5473-5479 Doi: 10.1002/cam4.3233 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Fastner, G; Sedlmayer, F; Widder, J; Metz, M; Geinitz, H; Kapp, K; Fesl, C; Sölkner, L; Greil, R; Jakesz, R; Kwasny, W; Heck, D; Bjelic-Radisic, V; Balic, M; Stöger, H; Wieder, U; Zwrtek, R; Semmler, D; Horvath, W; Melbinger-Zeinitzer, E; Wiesholzer, M; Wette, V; Gnant, M Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial.
Eur J Cancer. 2020; 127(4):12-20 Doi: 10.1016/j.ejca.2019.11.024
Web of Science PubMed FullText FullText_MUG

 

** Hatzl, S; Posch, F; Deutsch, A; Beham-Schmid, C; Stöger, H; Greinix, H; Pichler, M; Neumeister, P; Prochazka, KT Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma.
Hematol Oncol. 2020; 38(3):277-283 Doi: 10.1002/hon.2727 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Jahn-Kuch, D; Domke, A; Bitsche, S; Stöger, H; Avian, A; Jeitler, K; Posch, N; Siebenhofer, A End-of-life decision making by Austrian physicians - a cross-sectional study.
BMC Palliat Care. 2020; 19(1): 4-4. Doi: 10.1186/s12904-019-0509-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Klocker, EV; Barth, DA; Riedl, JM; Prinz, F; Szkandera, J; Schlick, K; Kornprat, P; Lackner, K; Lindenmann, J; Stöger, H; Stotz, M; Gerger, A; Pichler, M Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients.
Cancers (Basel). 2020; 12(5): Doi: 10.3390/cancers12051154 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Klöckl, MC; Kasparek, AK; Riedl, JM; Moik, F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer, T; Schilcher, G; Zitta, S; Rosenkranz, AR; Friedl, C; Stöger, H; Posch, F Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
Sci Rep. 2020; 10(1):11219 Doi: 10.1038/s41598-020-68010-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Barth, DA; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoeger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Posch, F C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study.
Cancers (Basel). 2020; 12(8): Doi: 10.3390/cancers12082319 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stöger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Maria Tea, MK; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M; Austrian Breast & Colorectal Cancer Study Group Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34).
Eur J Cancer. 2020; 132:43-52 Doi: 10.1016/j.ejca.2020.03.018
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Sande, MV; Callegaro, D; Wunder, J; Hayes, A; Leitner, L; Bergovec, M; Tunn, PU; van Praag, V; Fiocco, M; Panotopoulos, J; Willegger, M; Windhager, R; Dijkstra, SPD; van Houdt, WJ; Riedl, JM; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Andreou, D; Leithner, A; Gronchi, A; Haas, RL; Szkandera, J Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models.
Cancers (Basel). 2019; 12(1): Doi: 10.3390/cancers12010047 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stotz, M; Barth, DA; Riedl, JM; Asamer, E; Klocker, EV; Kornprat, P; Hutterer, GC; Prinz, F; Lackner, K; Stöger, H; Gerger, A; Pichler, M The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer.
Cancers (Basel). 2020; 12(7): Doi: 10.3390/cancers12071798 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Gerger, A; Riedl, JM; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial.
ANN ONCOL. 2020; 31: S1095-S1096.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.1331 [Onlinepräsentation] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Klec, C; Kapeller, A; Prinz, F; Trenk, C; Stoger, H; Pichler, M Dissecting the interplay of the long non-coding RNA NORAD and PARP inhibitors in triple negative breast cancer.
CANCER RES. 2020; 80(4):-San Antonio Breast Cancer Symposium; DEC 10-14, 2019; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS19-P1-05-13 [Poster]
Web of Science FullText FullText_MUG

 

** Klec, C; Schwarzenbacher, D; Gottschalk, B; Margit, R; Prinz, F; Bauernhofer, T; Stoeger, H; Graier, WF; Pichler, M Deciphering the interplay between nuclear RNA export factors and long non-coding RNAs in breast cancer metabolism.
ANN ONCOL. ESMO Breast Cancer Virtual Meeting 2020. 2020; 31(S2):S38-S38.-ESMO Breast Cancer Virtual Meeting; MAY 23-24, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.03.202 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Posch, F; Barth, D; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Riedl, JM C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: A bi-center study.
ANN ONCOL. 2020; 31: S286-S286.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.234 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Riedl, J; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E; Gerger, A Individualized cancer treatment based on molecular profiling of circulating tumor DNA in patients with advanced and refractory carcinoma: a prospective phase II trial.
ONCOL RES TREAT. 2020; 43(SUPPL 4):249-249.-DGHO Jahrestagung; 09.10. -11.10.2020; Basel (virtueller Kongress). [Oral Communication]
Web of Science

 

** Riedl, J; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Schaberl-Moser, R; Stotz, M; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A FOLFIRINOX versus Gemcitabine/nab-Paclitaxel as palliative first-line treatment of advanced pancreatic cancer: An Austrian observational Tri-Center comparative effectiveness analysis.
ONCOL RES TREAT. 2020; 43(SUPPL 4):215-215. [Poster]
Web of Science

 

** Riedl, JM; Posch, F; Gantschnigg, A; Horvath, L; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A FOLFIRINOX versus Gemcitabine/nabPaclitaxel as First-line palliative Therapy in advanced Pancreatic Cancer: a Propensity-Score Analysis.
WIEN KLIN WOCHENSCHR. Abstracts 51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):78-79.-51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
ANN ONCOL. 2020; 31: S942-S942.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.2013 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Schwarzenbacher, E; Moik, F; Horvath, L; Renneberg, F; Posch, F; Barth, D; Gantschnigg, A; Schaberl-Moser, R; Pichler, M; Stotz, M; Stoger, H; Ay, C; Greil, R; Gerger, A; Djanani, A; Schlick, K; Riedl, J Incidence, prediction and outcome of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of Gemcitabine/nab-Paclitxel or FOLFIRINOX.
ONCOL RES TREAT. 2020; 43(SUPPL 4):214-214. [Poster]
Web of Science

 

** Schwarzenbacher, E; Moik, F; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Ay, C; Stoger, H; Greil, R; Djanani, A; Gerger, A; Schlick, K; Riedl, JM Patterns of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of gemcitabine/nab-paclitxel or FOLFIRINOX.
ANN ONCOL. 2020; 31: S949-S950.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.2035 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Suppan, C; Steiner, D; Klocker, VE; Posch, F; Henzinger, EC; Stoeger, H; Dandachi, N; Balic, M Safety and clinical evaluation of dual inhibition with pertuzumab and trastuzumab in HER-2-positive breast cancer patients.
J CLIN ONCOL. 2020; 38(15): [Onlinepräsentation]
Web of Science FullText

 

2019

Originalarbeit (Zeitschrift)

** Balic, M; Hilbe, W; Gusel, S; Fiegl, M; Ludwig, H; Mayrbaurl, B; Thaler, J; Samonigg, H; Hegenbarth, K; Eisner, F; Mlineritsch, B; Greil, R; Schandl, MJ; Weltermann, A; Petzer, A; Fuchs, D; Stangl, W; Krippl, P; Stauder, R; Stoger, H Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria A cross-sectional multicentre observational study
MEMO-MAG EUR MED ONC. 2019; Doi: 10.1007/s12254-019-00542-7 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Barth, DA; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Stotz, M; Gerger, A Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Clin Transl Oncol. 2019; 21(8):1034-1043 Doi: 10.1007/s12094-019-02037-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Lembeck, AL; Posch, F; Klocker, EV; Szkandera, J; Schlick, K; Stojakovic, T; Kornprat, P; Lackner, C; Gerger, A; Stoeger, H; Stotz, M; Pichler, M Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
Clin Chem Lab Med. 2019; 57(5):740-744 Doi: 10.1515/cclm-2018-0016
Web of Science PubMed FullText FullText_MUG

 

** Moik, F; Riedl, JM; Winder, T; Terbuch, A; Rossmann, CH; Szkandera, J; Bauernhofer, T; Kasparek, AK; Schaberl-Moser, R; Reicher, A; Prinz, F; Pichler, M; Stöger, H; Stotz, M; Gerger, A; Posch, F Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.
Sci Rep. 2019; 9(1):5548 Doi: 10.1038/s41598-019-42069-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Müller, HD; Posch, F; Suppan, C; Bargfrieder, U; Gumpoldsberger, M; Hammer, R; Hauser, H; Dandachi, N; Prein, K; Stoeger, H; Lax, S; Balic, M Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy.
Ann Surg Oncol. 2019; 26(13):4274-4283 Doi: 10.1245/s10434-019-07741-w [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Ay, C; Stöger, H; Kreutz, R; Beyer-Westendorf, J Longitudinal kidney function trajectories predict major bleeding, hospitalization and death in patients with atrial fibrillation and chronic kidney disease.
Int J Cardiol. 2019; 282: 47-52. Doi: 10.1016/j.ijcard.2019.01.089
Web of Science PubMed FullText FullText_MUG

 

** Posch, F; Ay, C; Stöger, H; Kreutz, R; Beyer-Westendorf, J Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney disease.
Res Pract Thromb Haemost. 2019; 3(2): 207-216. Doi: 10.1002/rth2.12189 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Schmidinger, M; Pichler, R; Loidl, W; Bauernhofer, T; Kretz, M; Tinchon, C; Niedersüß-Beke, D; Pfleger, G; Wiesinger, CG; Vogl, U; Mitterberger, M; Stöger, H; Tulchiner, G; Kratochvill, F; Gerritsmann, H; Mraz, B; Marszalek, M Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study.
Clin Genitourin Cancer. 2019; 17(5):e957-e967-e957-e967 Doi: 10.1016/j.clgc.2019.05.017 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schwarzenbacher, D; Klec, C; Pasculli, B; Cerk, S; Rinner, B; Karbiener, M; Ivan, C; Barbano, R; Ling, H; Wulf-Goldenberg, A; Stanzer, S; Rinnerthaler, G; Stoeger, H; Bauernhofer, T; Haybaeck, J; Hoefler, G; Jahn, SW; Parrella, P; Calin, GA; Pichler, M MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.
Breast Cancer Res. 2019; 21(1): 20-20. Doi: 10.1186/s13058-019-1104-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; van Praag, VM; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Riedl, JM; Pichler, M; Gerger, A; Szkandera, J; Stöger, H; Smolle-Jüttner, FM; Liegl-Atzwanger, B; Fiocco, M; van de Sande, MA; Leithner, A Surgery for metachronous metastasis of soft tissue sarcoma - A magnitude of benefit analysis using propensity score methods.
Eur J Surg Oncol. 2019; 45(2):242-248 Doi: 10.1016/j.ejso.2018.06.019
Web of Science PubMed FullText FullText_MUG

 

** Terbuch, A; Posch, F; Bauernhofer, T; Pichler, M; Peinsith, H; Szkandera, J; Riedl, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Stotz, M; Gerger, A Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.
Anticancer Res. 2019; 39(10):5589-5596 Doi: 10.21873/anticanres.13753
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Aziz, F; Stelzl, A; Riedl, J; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Diabetes is a predictor for survival in soft tissue sarcoma patients
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S477-S477. [Poster]
Web of Science

 

** Aziz, F; Stelzl, A; Riedl, JM; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Association of serum glucose levels with disease free survival in soft tissue sarcoma patients
DIABETOLOGIA. 2019; 62: S562-S563.-55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 16-20, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Barth, DA; Riedl, JM; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A External validation and longitudinal extension of the LIPI (lung immune prognostic index) for immunotherapy outcomes in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 108-108. [Poster]
Web of Science

 

** Fastner, G; Sedlmayer, F; Widder, J; Metz, M; Geinitz, H; Kapp, K; Solkner, L; Greil, R; Jakesz, R; Kwasny, W; Heck, D; Bjelic-Radisic, V; Balic, M; Stoger, H; Wieder, U; Zwrtek, R; Semmler, D; Horvath, W; Melbinger-Zeinitzer, E; Wiesholzer, M; Wette, V; Gnant, M Antihormones with or without irradiation in breast cancer: 10-year results of the ABCSG 8A trial
RADIOTHER ONCOL. 2019; 133: S132-S133.-38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO); APR 26-30, 2019; Milan, ITALY. Doi: 10.1016/S0167-8140(19)30690-5 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Glantschnig, T; Posch, F; Firla, S; Moik, F; Ablasser, K; Binder, JS; Stoschitzky, G; Wallner, M; Von Lewinski, D; Stoger, H; Zirlik, A; Pichler, M; Rainer, PP Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
WIEN KLIN WOCHENSCHR. 2019; 131: 292-293. [Poster]
Web of Science

 

** Posch, F; Glantschnig, T; Firla, S; Smolle, M; Balic, M; Moik, F; Stoeger, H; Zirlik, A; Pichler, M; Rainer, P Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
EUR HEART J. 2019; 40: 3844-3844.-ESC Congress / World Congress of Cardiology; AUG 31-SEP 04, 2019; Paris, FRANCE. [Poster]
Web of Science

 

** Riedl, JM; Barth, D; Posch, F; Foris, V; Absenger, G; Mollnar, S; Pichler, M; Stotz, M; Stoger, H; Olschewski, H; Gerger, A Longitudinal C-reactive protein (CRP) trajectories predict immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 115-115. [Poster]
Web of Science

 

** Riedl, JM; Barth, DA; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A External validation and longitudinal extension of the LIPI (Lung Immune Prognostic Index) for immunotherapy outcomes in advanced non-small cell lung cancer
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Steger, G; Galid, A; Rechberger, E; Eisterer, W; Herz, W; Petru, E; Pasterk, C; Girschikofsky, M; Singer, C; Grunberger, B; Stoger, H; Marhold, M; Hitzl, D; Lindegger, N Exploring real world data treatment patterns and outcomes in participants with HER2+unresectable LA/mBC - Austrian participation in the prospective European registry SAMANTHA study
ONCOL RES TREAT. 2019; 42: 41-42.
Web of Science

 

** Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Niedersuss-Beke, D; Tinchon, C; Loidl, W; Pichler, M; Jahn, S; Stoger, H; Bauernhofer, T; Lymphopenia impairs response to 1st-line tyrosine kinase inhibitor therapy in patients with metastatic clear-cell renal cell carcinoma and modulates the relative efficacy of sunitinib and pazopanib
WIEN KLIN WOCHENSCHR. 2019; 131: S447-S447.-Frühjahrstagung der OeGHO; APR 11-13, 2019; Linz, AUSTRIA. [Poster]
Web of Science FullText

 

** Terzic, J; Tinchon, C; Stoger, H Smoker's Cough - what's behind it?
WIEN KLIN WOCHENSCHR. 2019; 131: S434-S435. [Oral Communication]
Web of Science

 

2018

Originalarbeit (Zeitschrift)

** Asamer, E; Szkandera, J; Gibiser, P; Lembeck, AL; Stojakovic, T; Kornprat, P; Lackner, C; Winder, T; Schlick, K; Stöger, H; Gerger, A; Pichler, M; Stotz, M Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis.
Wien Klin Wochenschr. 2018; 130(19-20):569-574 Doi: 10.1007/s00508-018-1383-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Brcic, L; Stanzer, S; Krenbek, D; Gruber-Moesenbacher, U; Absenger, G; Quehenberger, F; Valipour, A; Lindenmann, J; Stoeger, H; Al Effah, M; Fediuk, M; Balic, M; Popper, HH Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.
Virchows Arch. 2018; 472(4):589-598 Doi: 10.1007/s00428-018-2326-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Partl, R; Döller, C; Riedl, JM; Smolle, M; Leitner, L; Bergovec, M; Liegl-Atzwanger, B; Stotz, M; Bezan, A; Gerger, A; Pichler, M; Kapp, KS; Stöger, H; Leithner, A; Szkandera, J Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study.
Ann Surg Oncol. 2018; 25(3):776-783 Doi: 10.1245/s10434-017-6080-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Silina, K; Leibl, S; Mündlein, A; Moch, H; Siebenhüner, A; Samaras, P; Riedl, J; Stotz, M; Szkandera, J; Stöger, H; Pichler, M; Stupp, R; van den Broek, M; Schraml, P; Gerger, A; Petrausch, U; Winder, T Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer.
Oncoimmunology. 2018; 7(2):e1378844-e1378844 Doi: 10.1080/2162402X.2017.1378844 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Steger, G; Lüftner, D; Stöger, H; Thürlimann, B; Untch, M Management of HER2-Positive Early Breast Cancer.
Breast Care (Basel). 2018; 13(6):453-455 Doi: 10.1159/000494945 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Adiprasito, JB; Stiegelbauer, V; Seles, M; Klec, C; Pichler, GP; Resel, M; Posch, F; Lembeck, AL; Stöger, H; Szkandera, J; Pummer, K; Bauernhofer, T; Hutterer, GC; Gerger, A; Stotz, M; Pichler, M MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Int J Mol Sci. 2018; 19(10): Doi: 10.3390/ijms19103130 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Posch, F; Partl, R; Zurl, B; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.
Cancer Med. 2018; 7(2):508-514 Doi: 10.1002/cam4.1317 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Prochazka, KT; Posch, F; Deutsch, A; Beham-Schmid, C; Stöger, H; Abdyli, L; Greinix, H; Pichler, M; Neumeister, P Immunohistochemical double hit score enhances NCCN-IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma.
Br J Haematol. 2018; 183(1):142-146 Doi: 10.1111/bjh.14912 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Andritsch, E; Farkas, C; Zloklikovits, S; Gerger, A; Stoger, H Meaning of personalized medicine and targeted medical therapies for patients with cancer in the context of expectations and hope
ONCOL RES TREAT. 2018; 41: 34-34. [Oral Communication]
Web of Science

 

** Balic, M; Mueller, DH; Hammer, R; Gumpoldsberger, M; Suppan, C; Posch, F; Stoeger, H; Dandachi, N; Prein, K; Hauser, H; Lax, S Independent evaluation of prognostic value of residual cancer burden (RCB) score on disease free and overall survival of breast cancer patients treated with neoadjuvant systemic treatment at a single institution
CANCER RES. 2018; 78(4):-San Antonio Breast Cancer Symposium; DEC 05-09, 2017; San Antonio, TX. [Poster]
Web of Science

 

** Dubsky, PC; Fesl, C; Singer, CF; Pfeiler, G; Kronenwett, R; Hubalek, M; Bartsch, R; Stoeger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Tea, MKM; Wette, V; Petzner, AL; Sevelda, P; Egle, D; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Lax, S; Regitnig, P; Gnant, M; Filipits, M The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2-breast cancer patients from ABCSG 34
CANCER RES. 2018; 78(4):-San Antonio Breast Cancer Symposium; DEC 05-09, 2017; San Antonio, TX. [Oral Communication]
Web of Science

 

** Gnant, M; Steger, G; Greil, R; Fitzal, F; Mlineritsch, B; Manfreda, D; Tausch, C; Balic, M; Dubsky, P; Moik, M; Thaler, J; Egle, D; Bjelic-Radisic, V; Selim, U; Exner, R; Singer, C; Melbinger-Zeinitzer, E; Haslbauer, F; Stoger, H; Helfgott, R; Sevelda, P; Trapl, H; Wette, V; Solkner, L; Jakesz, R A prospective randomized multi-center phase-III trial of additional 2 versus additional 5 years of anastrozole after initial 5 years of adjuvant endocrine therapy - results from 3,484 postmenopausal women in the ABCSG-16 trial
CANCER RES. 2018; 78(4):-San Antonio Breast Cancer Symposium; DEC 05-09, 2017; San Antonio, TX. [Oral Communication]
Web of Science

 

** Leithner, A; van Praag, V; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Smolle-Juttner, FM; Fiocco, M; van de Sande, M; Riedl, J; Pichler, M; Gerger, A; Szkandera, J; Stoger, H; Liegl-Atzwanger, B; Smolle, MA Efficacy of metastasectomy on survival in patients with metachronous soft tissue sarcoma-metastasis: Results of a bi-centre study including 135 patients
ANN ONCOL. Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany. 2018; 29(S8):-43rd ESMO Congress (ESMO); OCT 19-23, 2018; Munich, GERMANY. [Poster]
Web of Science

 

** Mollnar, S; Pondorfer, P; Reinisch, S; Moik, F; Halm, M; Kasparek, AK; Klockl, MC; Stotz, M; Szkandera, J; Gerger, A; Vasicek, S; Weiland, T; Pichler, M; Stoger, H; Thurnher, D; Posch, F Definitive chemoradiotherapy with or without induction chemotherapy for unresectable squamous cell carcinoma of the head & neck: a propensity-score analysis
ONCOL RES TREAT. 2018; 41: 248-248. [Poster]
Web of Science

 

** Muller, HD; Posch, F; Gumpoldsberger, M; Suppan, C; Hammer, R; Hauser, H; Dandachi, N; Prein, K; Stoger, H; Lax, S; Balic, M Prognostic impact of the Residual Cancer Burden (RCB) index on recurrence-free survival of breast cancer patients recieving neoadjuvant therapy
ONCOL RES TREAT. 2018; 41: 297-298. [Poster]
Web of Science

 

Abstract (Konferenzband)

** Klöckl, MC; Kasparek, AK; Riedl, J; Moik ,F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer T; Stöger H; Posch, F Estimated versus measured glomerular filtration rate to evaluate kidney function in patients with cancer undergoing cisplatin-based chemotherapy
Oncology Research and Treatment . 2018; 41(Suppl4):224-224.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 ) [Poster]
Web of Science FullText

 

** Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Pichler, M; Jahn, S; Stöger, H; Bauernhofer, T Lymphopenia impairs response to 1st-line therapy with sunitinib and pazopanib in patients with metastatic clear-cell renal cell carcinoma.
Oncology Research and Treatment . 2018; 41(Suppl4):42-43.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie,; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 ) [Oral Communication]
Web of Science FullText

 

2017

Originalarbeit (Zeitschrift)

** Benezeder, T; Tiran, V; Treitler, AAN; Suppan, C; Rossmann, C; Stoeger, H; Cote, RJ; Datar, RH; Balic, M; Dandachi, N Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients.
Oncotarget. 2017; 8(54):92483-92496 Doi: 10.18632/oncotarget.21426 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Leitner, L; Bergovec, M; Bezan, A; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Leithner, A; Szkandera, J Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Clin Orthop Relat Res. 2017; 475(5):1427-1435 Doi: 10.1007/s11999-017-5232-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Richtig, G; Aigelsreiter, A; Schwarzenbacher, D; Ress, AL; Adiprasito, JB; Stiegelbauer, V; Hoefler, G; Schauer, S; Kiesslich, T; Kornprat, P; Winder, T; Eisner, F; Gerger, A; Stoeger, H; Stauber, R; Lackner, C; Pichler, M SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
PLoS One. 2017; 12(11):e0187814-e0187814 Doi: 10.1371/journal.pone.0187814 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Posch, F; Bezan, A; Szkandera, J; Smolle, MA; Winder, T; Rossmann, CH; Schaberl-Moser, R; Pichler, M; Stotz, M; Stöger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.
BMC Cancer. 2017; 17(1):415-415 Doi: 10.1186/s12885-017-3392-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Posch, F; Moik, F; Bezan, A; Szkandera, J; Smolle, MA; Kasparek, AK; Pichler, M; Stöger, H; Stotz, M; Gerger, A Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting.
Oncotarget. 2017; 8(56):96048-96061 Doi: 10.18632/oncotarget.21647 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stiegelbauer, V; Vychytilova-Faltejskova, P; Karbiener, M; Pehserl, AM; Reicher, A; Resel, M; Heitzer, E; Ivan, C; Bullock, M; Ling, H; Deutsch, A; Wulf-Goldenberg, A; Adiprasito, JB; Stoeger, H; Haybaeck, J; Svoboda, M; Stotz, M; Hoefler, G; Slaby, O; Calin, GA; Gerger, A; Pichler, M miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5.
Clin Cancer Res. 2017; 23(17):5255-5266 Doi: 10.1158/1078-0432.CCR-17-0023 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Herzog, SA; Pichler, M; Smolle, M; Riedl, J; Rossmann, C; Bezan, A; Stöger, H; Renner, W; Berghold, A; Gerger, A Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
Anticancer Res. 2017; 37(4):2011-2018 Doi: 10.21873/anticanres.11545 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Terbuch, A; Posch, F; Annerer, LM; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Long-term cardiovascular complications in stage I seminoma patients.
Clin Transl Oncol. 2017; 19(11):1400-1408 Doi: 10.1007/s12094-017-1742-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Tiran, V; Lindenmann, J; Brcic, L; Heitzer, E; Stanzer, S; Tabrizi-Wizsy, NG; Stacher, E; Stoeger, H; Popper, HH; Balic, M; Dandachi, N Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition.
Sci Rep. 2017; 7(1):10040-10040 Doi: 10.1038/s41598-017-09929-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Bezan, A; Pasch, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Zurl, B; Kapp, K; Stager, H; Gerger, A; Stotz, M Clinical characterization of febrile neutropenia episodes in patients with testicular germ cell tumors.
J CLIN ONCOL. 2017; 35: -53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET; JUN 02-07, 2017; Chicago, IL. Doi: 10.1200/JCO.2017.35.15_suppl.e16038 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Bjelic-Radisic, V; Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stoger, H; Pichler, A; Petru, E; Greil, R; Wette, V; Petzer, A; Sevelda, P; Egle, D; Dubsky, P; Fitzal, F; Jakesz, R; Balic, M; Frantal, S; Solkner, L; Gnant, M Quality-of-life results from a randomized, phase-II-study of the therapeutic cancer vaccine L-BLP25 (Stimuvax (R)) in the preoperative treatment of women with primary breast cancer (ABCSG-34)
ANN ONCOL. 2017; 28: -42nd European-Society-for-Medical-Oncology Congress (ESMO); SEP 08-12, 2017; Madrid, SPAIN. [Oral Communication]
Web of Science

 

** Schmidinger, M; Pichler, R; Bauernhofer, T; Kretz, M; Tinchon, C; Niedersuss-Beke, D; Pfleger, G; Heinrich, E; Vogl, U; Mitterberger, M; Stoger, H; Tulchiner, G; Kratochvill, F; Mraz, B; Marszalek, M Real-world evidence data on aRCC treatment in Austria: the RELACS study
ONCOL RES TREAT. 2017; 40: 276-276.-Jahrestagung der DGHO, OeGHO, SGMO, SGH; SEP 29-OCT 3, 2017; Stuttgart, Germany. [Oral Communication]
Web of Science

 

** Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stoeger, H; Pichler, A; Petru, E; Greil, R; Rudas, M; Tea, MK; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Michael, G Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)
CANCER RES. 2017; 77: -San Antonio Breast Cancer Symposium; DEC 06-10, 2016; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS16-P6-10-01 [Poster]
Web of Science FullText FullText_MUG

 

2016

Abstract (Zeitschrift)

** Riedl, J; Posch, F; Stotz, M; Bezan, A; Winder, T; Schaberl-Moser, R; Pichler, M; Stoeger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw370.107 [Poster]
Web of Science FullText FullText_MUG

 

** Winder, T; Posch, F; Asamer, E; Stotz, M; Siebenhuner, A; Schlick, K; Magnes, T; Samaras, P; Szkandera, J; Clavien, PA; Neureiter, D; Greil, R; Pestalozzi, BC; Stoeger, H; Gerger, A; Egle, A; Pichler, M An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw371.77 [Poster]
Web of Science FullText FullText_MUG

 

2015

Originalarbeit (Zeitschrift)

** Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Knauer, M; Moik, M; Jakesz, R; Seifert, M; Taucher, S; Bjelic-Radisic, V; Balic, M; Eidtmann, H; Eiermann, W; Steger, G; Kwasny, W; Dubsky, P; Selim, U; Fitzal, F; Hochreiner, G; Wette, V; Sevelda, P; Ploner, F; Bartsch, R; Fesl, C; Greil, R; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.
Ann Oncol. 2015; 26(2):313-320 Doi: 10.1093/annonc/mdu544 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gnant, M; Sestak, I; Filipits, M; Dowsett, M; Balic, M; Lopez-Knowles, E; Greil, R; Dubsky, P; Stoeger, H; Rudas, M; Jakesz, R; Ferree, S; Cowens, JW; Nielsen, T; Schaper, C; Fesl, C; Cuzick, J Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.
Ann Oncol. 2015; 26(8):1685-1691 Doi: 10.1093/annonc/mdv215 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fallbericht

** Eisner, F; Pichler, M; Goletz, S; Stoeger, H; Samonigg, H A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options.
J Clin Pathol. 2015; 68(12):1044-1046 Doi: 10.1136/jclinpath-2015-202996 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2014

Originalarbeit (Zeitschrift)

** Brämswig, K; Ploner, F; Martel, A; Bauernhofer, T; Hilbe, W; Kühr, T; Leitgeb, C; Mlineritsch, B; Petzer, A; Seebacher, V; Stöger, H; Girschikofsky, M; Hochreiner, G; Ressler, S; Romeder, F; Wöll, E; Brodowicz, T Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.
Anticancer Drugs. 2014; 25(7):848-853 Doi: 10.1097/CAD.0000000000000108
Web of Science PubMed FullText FullText_MUG

 

** Filipits, M; Nielsen, TO; Rudas, M; Greil, R; Stöger, H; Jakesz, R; Bago-Horvath, Z; Dietze, O; Regitnig, P; Gruber-Rossipal, C; Müller-Holzner, E; Singer, CF; Mlineritsch, B; Dubsky, P; Bauernhofer, T; Hubalek, M; Knauer, M; Trapl, H; Fesl, C; Schaper, C; Ferree, S; Liu, S; Cowens, JW; Gnant, M; Austrian Breast and Colorectal Cancer Study Group The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.
Clin Cancer Res. 2014; 20(5):1298-1305 Doi: 10.1158/1078-0432.CCR-13-1845 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gnant, M; Filipits, M; Greil, R; Stoeger, H; Rudas, M; Bago-Horvath, Z; Mlineritsch, B; Kwasny, W; Knauer, M; Singer, C; Jakesz, R; Dubsky, P; Fitzal, F; Bartsch, R; Steger, G; Balic, M; Ressler, S; Cowens, JW; Storhoff, J; Ferree, S; Schaper, C; Liu, S; Fesl, C; Nielsen, TO; Austrian Breast and Colorectal Cancer Study Group Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
Ann Oncol. 2014; 25(2):339-345 Doi: 10.1093/annonc/mdt494 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Steger, GG; Greil, R; Lang, A; Rudas, M; Fitzal, F; Mlineritsch, B; Hartmann, BL; Bartsch, R; Melbinger, E; Hubalek, M; Stoeger, H; Dubsky, P; Ressler, S; Petzer, AL; Singer, CF; Muss, C; Jakesz, R; Gampenrieder, SP; Zielinski, CC; Fesl, C; Gnant, M Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
ANN ONCOL. 2014; 25(2): 366-371. Doi: 10.1093/annonc/mdt508 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Originalarbeit (Zeitschrift)

** Andritsch, E; Stöger, H; Bauernhofer, T; Andritsch, H; Kasparek, AK; Schaberl-Moser, R; Ploner, F; Samonigg, H The ethics of space, design and color in an oncology ward.
Palliat Support Care. 2013; 11(3):215-221 Doi: 10.1017/S1478951512000077
Web of Science PubMed FullText FullText_MUG

 

** Gnant, M; Pfeiler, G; Stöger, H; Mlineritsch, B; Fitzal, F; Balic, M; Kwasny, W; Seifert, M; Stierer, M; Dubsky, P; Greil, R; Steger, G; Samonigg, H; Fesl, C; Jakesz, R The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.
Br J Cancer. 2013; 109(3):589-596 Doi: 10.1038/bjc.2013.367 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pfeiler, G; Stöger, H; Dubsky, P; Mlineritsch, B; Singer, C; Balic, M; Fitzal, F; Moik, M; Kwasny, W; Selim, U; Renner, K; Ploner, F; Steger, GG; Seifert, M; Hofbauer, F; Sandbichler, P; Samonigg, H; Jakesz, R; Greil, R; Fesl, C; Gnant, M; ABCSG Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
Br J Cancer. 2013; 108(7):1408-1414 Doi: 10.1038/bjc.2013.114 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stöger, H Are the new breast cancer subtypes (luminal A, B etc.) of practical impact? Yes].
Dtsch Med Wochenschr. 2013; 138(41):2096-2096 Doi: 10.1055/s-0033-1349531
Web of Science PubMed FullText FullText_MUG

 

2012

Originalarbeit (Zeitschrift)

** Dubsky, PC; Jakesz, R; Mlineritsch, B; Pöstlberger, S; Samonigg, H; Kwasny, W; Tausch, C; Stöger, H; Haider, K; Fitzal, F; Singer, CF; Stierer, M; Sevelda, P; Luschin-Ebengreuth, G; Taucher, S; Rudas, M; Bartsch, R; Steger, GG; Greil, R; Filipcic, L; Gnant, M Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.
J Clin Oncol. 2012; 30(7):722-728 Doi: 10.1200/JCO.2011.36.8993 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gary, T; Belaj, K; Steidl, K; Pichler, M; Eisner, F; Stöger, H; Hafner, F; Froehlich, H; Samonigg, H; Pilger, E; Brodmann, M Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival.
Br J Cancer. 2012; 107(8):1244-1248 Doi: 10.1038/bjc.2012.401 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Originalarbeit (Zeitschrift)

** Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Heck, D; Menzel, C; Jakesz, R; Seifert, M; Hubalek, M; Pristauz, G; Bauernhofer, T; Eidtmann, H; Eiermann, W; Steger, G; Kwasny, W; Dubsky, P; Hochreiner, G; Forsthuber, EP; Fesl, C; Greil, R; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Lancet Oncol. 2011; 12(7):631-641 Doi: 10.1016/S1470-2045(11)70122-X
Web of Science PubMed FullText FullText_MUG

 

** Pfeiler, G; Königsberg, R; Fesl, C; Mlineritsch, B; Stoeger, H; Singer, CF; Pöstlberger, S; Steger, GG; Seifert, M; Dubsky, P; Taucher, S; Samonigg, H; Bjelic-Radisic, V; Greil, R; Marth, C; Gnant, M Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial.
J Clin Oncol. 2011; 29(19):2653-2659 Doi: 10.1200/JCO.2010.33.2585 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Heck, D; Steger, G; Jakesz, R; Singer, C; Dubsky, P; Greil, R Preplanned subgroup analysis of ABCSG-12 suggests that benefits of adjuvant zoledronic acid (ZOL) are most pronounced in lowest estrogen environment
BREAST. 2011; 20: S69-S69.St. Gallen . Doi: 10.1016/S0960-9776(11)70228-4 [Poster]
Web of Science FullText FullText_MUG

 

** Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Poestlberger, S; Steger, G; Jakesz, R; Singer, C; Eidtmann, H; Greil, R 62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer
BONE. 2011; 48(1):S17-S17. Doi: 10.1016/j.bone.2010.10.045 [Oral Communication]
Web of Science FullText FullText_MUG

 

2010

Originalarbeit (Zeitschrift)

** Knechtel, G; Stoeger, H; Szkandera, J; Dorr, K; Beham, A; Samonigg, H Desmoid tumor treated with polychemotherapy followed by imatinib: a case report and review of the literature.
Case Rep Oncol. 2010; 3(2): 287-293. Doi: 10.1159/000318873 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Poestlberger, S; Steger, GG; Jakesz, R; Singer, CF; Eidtmann, H; Greil, R ADJUVANT ENDOCRINE THERAPY, ALONE OR IN COMBINATION WITH ZOLEDRONIC ACID (ZOL), IN PREMENOPAUSAL PATIENTS (PTS) WITH ENDOCRINE-RESPONSIVE EARLY BREAST CANCER (EBC): SUBGROUP ANALYSES OF ABCSG-12
ANN ONCOL. 2010; 21: 79-79.
Web of Science

 

** Steger, GG; Greil, R; Jakesz, R; Lang, A; Mlineritsch, B; Rudas, M; Marth, C; Stoeger, H; Singer, CF; Gnant, M Independent prognostic factors for response: updated results of the ABCSG-24 study evaluating the addition of capecitabine to epirubicin-docetaxel neoadjuvant therapy for early breast cancer (EBC)
EJC SUPPL. 2010; 8(3): 60-60. Doi: 10.1016/S1359-6349(10)70040-9 [Poster]
Web of Science FullText FullText_MUG

 

** Steger, GG; Greil, R; Jakesz, R; Mlineritsch, B; Lang, A; Rudas, M; Marth, C; Stoeger, H; Singer, CF; Gnant, M ABCSG-24: EFFICACY OF ANTHRACYCLINE- AND TAXANE-BASED NEOADJUVANT THERAPY +/- CAPECITABINE (C) IN TRIPLE-NEGATIVE EARLY BREAST CANCER (TNBC)
ANN ONCOL. 2010; 21: 79-79.
Web of Science

 

2008

Originalarbeit (Zeitschrift)

** Dubsky, P; Sevelda, P; Jakesz, R; Hausmaninger, H; Samonigg, H; Seifert, M; Denison, U; Mlineritsch, B; Steger, G; Kwasny, W; Stöger, H; Bartsch, R; Stierer, M; Taucher, S; Fridrik, M; Schippinger, W; Greil, R; Pötter, R; Gnant, M; Austrian Breast and Colorectal Cancer Study Group Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Clin Cancer Res. 2008; 14(7):2082-2087 Doi: 10.1158/1078-0432.CCR-07-2068 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Rudas, M; Lehnert, M; Huynh, A; Jakesz, R; Singer, C; Lax, S; Schippinger, W; Dietze, O; Greil, R; Stiglbauer, W; Kwasny, W; Grill, R; Stierer, M; Gnant, MF; Filipits, M; Austrian Breast and Colorectal Cancer Study Group Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
CLIN CANCER RES. 2008; 14(6): 1767-1774. Doi: 10.1158/1078-0432.CCR-07-4122 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2006

Originalarbeit (Zeitschrift)

** Bjelic-Radisic, V; Stöger, H; Winter, R; Beham-Schmid, C; Petru, E Long-term control of bone marrow carcinosis and severe thrombocytopenia with standard-dose chemotherapy in a breast cancer patient: a case report.
Anticancer Res. 2006; 26(2B):1627-1630 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText Google Scholar

 

** Friess, H; Langrehr, JM; Oettle, H; Raedle, J; Niedergethmann, M; Dittrich, C; Hossfeld, DK; Stoger, H; Neyns, B; Herzog, P; Piedbois, P; Dobrowolski, F; Scheithauer, W; Hawkins, R; Katz, F; Balcke, P; Vermorken, J; van Belle, S; Davidson, N; Esteve, AA; Castellano, D; Kleeff, J; Tempia-Caliera, AA; Kovar, A; Nippgen, J A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer
BMC CANCER. 2006; 6: 285 Doi: 10.1186/1471-2407-6-285 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hofmann, G; Bauernhofer, T; Krippl, P; Lang-Loidolt, D; Horn, S; Goessler, W; Schippinger, W; Ploner, F; Stoeger, H; Samonigg, H Plasmapheresis reverses all side-effects of a cisplatin overdose--a case report and treatment recommendation.
BMC Cancer. 2006; 6(2):1-1 Doi: 10.1186/1471-2407-6-1 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

2003

Abstract (Zeitschrift)

** Samonigg, H; Hofmann, G; Bauernhofer, T; Balic, M; Stöger, H; Groiss, F; Himmler, G; Schuster, M; Rosenkaimer, F; Loibner, H Phase if trial to explore the influence of concomitant chemotherapies on the immunogenicity of the cancer vaccine IGN101 in patients with epithelial cancers
J IMMUNOTHER 2003 26: S14-S14.
Web of Science

 

2002

Originalarbeit (Zeitschrift)

** Heidemann, E; Stoeger, H; Souchon, R; Hirschmann, WD; Bodenstein, H; Oberhoff, C; Fischer, JT; Schulze, M; Clemens, M; Andreesen, R; Mahlke, M; König, M; Scharl, A; Fehnle, K; Kaufmann, M Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial.
Ann Oncol. 2002; 13(11):1717-1729 Doi: 10.1096/annonc/mdf306 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Loimer, L; Bichler, A; Brezinka, C; Brown, A; Denk, W; Friedrich, E; Hohenbichler, U; Mayerhofer, K; Rieger, A; Schaffer, M; Spacek, K; Stadlbauer, G; Stöger, H; Vytiska-Binsdorfer, E; Pateisky, N Guideline of the Austrian Society of Gynecology and Obstetrics on suspected sexual offenses. November 2001 status].
Wien Klin Wochenschr. 2002; 114(5-6):233-235
Web of Science PubMed

 

** Wehrschütz, M; Stöger, H; Ploner, F; Hofmann, G; Wolf, G; Höfler, G; Krippl, P; Samonigg, H Seminoma metastases mimicking primary pancreatic cancer.
Onkologie. 2002; 25(4):371-373 Doi: 10.1159/000066057 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2001

Originalarbeit (Zeitschrift)

** Kapp, KS; Geyer, E; Gebhart, FH; Oechs, AC; Berger, A; Hebenstreit, J; Stoeger, H Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal.
Int J Radiat Oncol Biol Phys. 2001; 49(4):997-1005 Doi: 10.1016/s0360-3016(00)01427-9
Web of Science PubMed FullText FullText_MUG

 

2000

Abstract (Zeitschrift)

** Kuss, I; Wagner, P; Genser, B; Stöger, H; Kasparek, AK; Samonigg, H Low dose weekly anthracycline chemotherapy for breast cancer patients with bone marrow infiltration.
ANN ONCOL 2000 11: 38-38.
Web of Science

 

1999

Originalarbeit (Zeitschrift)

** Samonigg, H; Wilders-Truschnig, M; Kuss, I; Plot, R; Stöger, H; Schmid, M; Bauernhofer, T; Tiran, A; Pieber, T; Havelec, L; Loibner, H A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer.
J Immunother. 1999; 22(6):481-488 Doi: 10.1097/00002371-199911000-00002
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stranzl, H; Mayer, R; Quehenberger, F; Prettenhofer, U; Willfurth, P; Stöger, H; Hackl, A Adjuvant radiotherapy in male breast cancer.
Radiother Oncol. 1999; 53(1):29-35 Doi: 10.1016/S0167-8140(99)00122-X
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Bauernhofer, T; Stöger, H; Kasparek, AK; Ploner, F; Kuss, I; Pieber, TR; Kotz, R; Samonigg, H Combined treatment of metastatic osteosarcoma of the spine.
Oncology. 1999; 57(4):265-268 Doi: 10.1159/000012058 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Bauernhofer, T; Schmid, M; Stoeger, H; Kasparek, AK; Ploner, F; Kuss, I; Gilli, R; Lanzer, H; Samonigg, H Sequential dose intensive chemotherapy with cyclophosphamide and carboplatin (CC) with peripheral blood progenitor cell (PBPC) support in metastatic breast cancer patients.
BONE MARROW TRANSPLANT 1999 23: S37-S37.
Web of Science

 

1998

Originalarbeit (Zeitschrift)

** Stöger, H; Samonigg, H; Krainer, M; Ploszczynski, M; Nirnberger, G; Maca, S; Hehenwarter, W; Wirth, M; Schüller, J; Vavra, N; Scheithauer, W; Kornek, G; Stierer, M; Zielinski, CC Dose intensification of epidoxorubicin and cyclophosphamide in metastatic breast cancer: a randomised study with two schedules of granulocyte-macrophage colony stimulating factor.
Eur J Cancer. 1998; 34(4):482-488 Doi: 10.1016/S0959-8049(97)10039-9
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1997

Kurzbericht/Letter

** Watzinger, N; Stöger, H; Ratschek, M Coronary embolization in a woman with advanced breast cancer.
N Engl J Med. 1997; 336(15):1104-1105 Doi: 10.1056/NEJM199704103361515 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1996

Übersichtsarbeit

** Bauernhofer, T; Stöger, H; Schmid, M; Smola, M; Gürtl-Lackner, B; Höfler, G; Ranner, G; Reisinger, E; Samonigg, H Sequential treatment of recurrent mesenteric desmoid tumor.
Cancer. 1996; 77(6):1061-1065 Doi: 10.1002/(SICI)1097-0142(19960315)77:6<1061::AID-CNCR9>3.0.CO;2-K (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1995

Originalarbeit (Zeitschrift)

** Pakisch, B; Stöger, H; Poschauko, H; Samonigg, H; Bauernhofer, T; Pojer, E; Leitner, H; Stuecklschweiger, G; Peichl, KH; Quehenberger, F; Hackl, A Treatment Results in Males with Breast-Cancer
EUROPEAN RADIOL. 1995; 5: 172-175. Doi: 10.1007/BF00957114
Web of Science FullText FullText_MUG

 

** Schmid, M; Samonigg, H; Stöger, H; Auer, H; Sternthal, MH; Wilders-Truschnig, M; Reisinger, EC Use of interferon gamma and mebendazole to stop the progression of alveolar hydatid disease: case report.
Clin Infect Dis. 1995; 20(6):1543-1546 Doi: 10.1093/clinids/20.6.1543 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Trauner, M; Klimpfinger, M; Stauber, RE; Schreiber, F; Stöger, H; Krejs, GJ Laparoscopic diagnosis of peritoneal serous papillary carcinoma.
Endoscopy. 1995; 27(4):337-341 Doi: 10.1055/s-2007-1005704 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** SAMONIGG, H; WILDERSTRUSCHNIG, M; KUSS, I; PLOT, R; STOGER, H; SCHMID, M; BAUERNHOFER, T; TIRAN, A; HAVELEC, L; LOIBNER, H IMMUNIZATION WITH ANTIIDIOTYPE VACCINE SCV-106 PROLONGS SURVIVAL-TIME OF CANCER-PATIENTS WITH METASTATIC COLORECTAL-CANCER - A RANDOMIZED DOUBLE-BLIND CLINICAL-TRIAL
EUR J CANCER 1995 31A: 45-45.
Web of Science

 

1994

Originalarbeit (Zeitschrift)

** Stöger, H; Bauernhofer, T; Kasparek, AK; Schmid, M; Moser, R; Ploner, F; Derstvenscheg, E; Kuss, I; Wilders-Truschnig, M; Steindorfer, P Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study.
Cancer Chemother Pharmacol. 1994; 34(1):75-78 Doi: 10.1007/BF00686116
Web of Science PubMed FullText FullText_MUG

 

** Stöger, H; Bauernhofer, T; Moser, R; Derstvenscheg, E; Schmid, M; Ploner, F; Pakisch, B; Wilders-Truschnig, M; Haas, J; Steindorfer, P Breast cancer in the man: a report of 30 patients].
Wien Klin Wochenschr. 1994; 106(18):575-580
Web of Science PubMed Google Scholar

 

** Stöger, H; Bauernhofer, T; Schmid, M; Ploner, F; Moser, R; Derstvenscheg, E; Steindorfer, P; Wilders-Truschnig, M; Kuss, I; Samonigg, H A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients.
Cancer Chemother Pharmacol. 1994; 35(2):174-178 Doi: 10.1007/BF00686643
Web of Science PubMed FullText FullText_MUG

 

** Stöger, H; Schmid, M; Bauernhofer, T; Moser, R; Ploner, F; Derstvenscheg, E; Kasparek, AK; Kuss, I; Wilders-Truschnig, M; Lackner, C A phase II trial of weekly high-dose folinic acid and 5-fluorouracil in combination with epirubicin as salvage chemotherapy in advanced breast cancer.
Oncology. 1994; 51(6):518-522 Doi: 10.1159/000227397
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stöger, H; Wilders-Truschnig, M; Schmid, M; Petek, W; Samonigg, H Scurvy after a suicide attempt by starvation].
Dtsch Med Wochenschr. 1994; 119(16):589-592 Doi: 10.1055/s-2008-1058734 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Note

** Silly, H; Wilderstruschnig, M; Brezinschek, R; Brezinschek, HP; Schmid, M; Kuss, I; Mucher, K; Stöger, H; Samonigg, H Varying Amounts of Tumor-Cells in the Bone-Marrow of Patients with Nonmetastatic Colorectal-Cancer
ONKOLOGIE. 1994; 17: 184-186. Doi: 10.1159/000218406
Web of Science FullText FullText_MUG

 

1993

Originalarbeit (Zeitschrift)

** Stöger, H; Wilders-Truschnig, M; Samonigg, H; Schmid, M; Bauernhofer, T; Tiran, A; Tas, M; Drexhage, HA The presence of immunosuppressive 'p15E-like' factors in the serum and urine of patients suffering from malign and benign breast tumours.
Clin Exp Immunol. 1993; 93(3):437-441 Doi: 10.1111/j.1365-2249.1993.tb08197.x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

1992

Originalarbeit (Zeitschrift)

** Samonigg, H; Wilders-Truschnig, M; Loibner, H; Plot, R; Rot, A; Kuss, I; Werner, G; Stöger, H; Wrann, M; Herlyn, D Immune response to tumor antigens in a patient with colorectal cancer after immunization with anti-idiotype antibody.
Clin Immunol Immunopathol. 1992; 65(3):271-277 Doi: 10.1016/0090-1229(92)90157-J (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Silly, H; Samonigg, H; Stöger, H; Brezinschek, HP; Wilders-Truschnig, M Micrometastatic tumour cells in bone marrow in colorectal cancer.
Lancet. 1992; 340(8830):1288-1288 Doi: 10.1016/0140-6736(92)92987-Q
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1991

Originalarbeit (Zeitschrift)

** Samonigg, H; Stöger, H; Kasparek, AK; Schmid, M; Dusleag, J; Pfeiffer, K; Smola, M; Steindorfer, P; Lechner, P Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer.
Cancer Chemother Pharmacol. 1991; 27(6):477-480 Doi: 10.1007/BF00685163
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1990

Originalarbeit (Zeitschrift)

** Samonigg, H; Kasparek, AK; Stöger, H; Schmid, M; Eber, B; Stark, G; Weinrauch, V; Pfeiffer, K; Smola, M; Steindorfer, P 4'-O-tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II study.
Cancer Chemother Pharmacol. 1990; 26(4):293-296 Doi: 10.1007/BF02897233
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Samonigg, H; Stöger, H; Bauernhofer, T; Schmid, M; Kasparek, AK; Kuss, I; Kaul, M; Heberle, U; Vieder, L; Dusleag, J Combination therapy of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose folinic acid in patients with advanced breast cancer: a phase I-II study (preliminary results).
Am J Clin Oncol. 1990; 13 Suppl 1(4):S44-S47 Doi: 10.1097/00000421-199012001-00010
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Scheithauer, W; Samonigg, H; Depisch, D; Schüller, J; Hausmaninger, H; Wiegele, J; Zielinsky, C; Stöger, H; Haider, K; Preis, P Pirarubicin (4'-o-tetrahydropyranil-adriamycin) for treatment of advanced breast cancer. A Clinical Phase II study.
Invest New Drugs. 1990; 8(2):207-210 Doi: 10.1007/BF00177262
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Loibner, H; Plot, R; Rot, A; Werner, G; Wrann, M; Samonigg, H; Schmid, M; Stöger, H; Truschnig, M; Herlyn, D Immunoreactivity of patient with colorectal cancer metastasis after immunisation with anti-idiotypes.
Lancet. 1990; 335(8682):171-171 Doi: 10.1016/0140-6736(90)90044-6 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum